This novel treatment bridges traditional neurology and neurointerventional surgery, offering a specialized alternative for ...

Thirteen percent of Americans—about 38 million people—suffer from migraine, and every one of them has a different experience with the condition. Treatment has to be as individualized as they are.

Insights from AHS 2026, including anticipated presentations, key takeaways, and how new research in migraine treatment will affect patient care.

Chronic migraine can greatly affect your life, especially when the pain arrives suddenly and traditional medications don't seem to help. An alternative remedy currently being studied may offer help ...

Migraine attacks often become less frequent and less severe after 60. For those who still need treatment, the newer ...

Emgality is a monthly subcutaneous injection used to prevent episodic and chronic migraine. Migraine is a condition that causes intense throbbing or pulsating on one side of the head. Migraine may ...

Discover how "gepants" (CGRP inhibitors) are changing migraine care. Learn about their use for acute relief and prevention, ...

Learn when to consider preventive migraine treatment, explore traditional and new therapies, and understand options like CGRP inhibitors, Botox, and neuromodulation.

The upcoming AHS Scientific Meeting will showcase the latest and most impactful science in migraine treatment, according to Nan Cheng, MD. A central focus will be on PACAP, a small molecule that could ...

A study has found that treatment with Wegovy (semaglutide) led to reduced triptan usage in women. However, no significant ...

Neurologist Dr. Susan Lee answers common questions about new treatments for migraine and where the future of migraine research is headed. Standard treatments taken at the onset of a migraine episode ...

A headache before your period is likely a migraine attack that’s triggered by hormonal changes. Learn how to recognize ...